Raphael Pharmaceutical Inc Com – Material Contracts Watch

EX-10.13

from 10-K 1 page December 27, 2025 Dear Mr. Ajay Kumar Dhadha, Chairman of the Board of Directors Re: Extension of Service Agreement /S/ Shlomo Pilo Shlomo Pilo, CEO & Director

12/34/56

EX-10.12

from 10-K 1 page December 27, 2025 Dear Mr. Shlomo Pilo, Chief Executive Officer and Director Re: Extension of Service Agreement /S/ Guy Ofir Guy Ofir, CFO & Director

12/34/56

EX-10.11

from 10-K 1 page December 27, 2025 Dear Adv. Guy Ofir, Chief Financial Officer and Director Re: Extension of Service Agreement /S/ Shlomo Pilo Shlomo Pilo, CEO & Director

12/34/56

EX-10.10

from 10-K 1 page December 27, 2025 Dear Dr. Igal Louria Hayon, Re: Extension of Consulting/Advisory Service Agreement /S/ Shlomo Pilo Shlomo Pilo, CEO & Director

12/34/56

EX-10.1

from 10-Q 4 pages Amendment Dated July 28, 2025 to Sponsored Research Agreement

12/34/56

EX-10.1

from 10-Q 17 pages Form of Subscription Agreement

12/34/56

EX-10.9

from 10-K 3 pages Director and Chairman of the Board Services Agreement

12/34/56

EX-10.8

from 10-K 3 pages This Service Agreement (This "Agreement") Is Made as of March 10, 2025, by and Between Raphael Pharmaceutical Inc. (The "Company"), and Prof. Eliya Yehuda I.D 025721069, an Individual Residing in Israel (The "Director"/So Called “Yehuda”). Recitals 1. Appointment of Director; Relationship of Company and Yehuda

12/34/56

EX-10.7

from 10-K 4 pages This Service Agreement (This “Agreement”) Is Made as of 3rd of March, 2025, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Dr. Igal Louria Hayon, an Individual Residing at Israel (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal

12/34/56

EX-10.6

from 10-K 4 pages This Operations Agreement (This “Agreement”) Is Made as of March, 3rd ,2025, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Model Engineering & Investments. Srl a Romanian Company No. J40/1123/2007 and/or Adv’ Guy Ofir I.D. 172910400069, an Individual Residing at Romaina (The “CFO, Legal Adviser & Director”). Recitals 1. Appointment of CFO, Legal Adviser & Director and It’s Relationship With the Company

12/34/56

EX-10.5

from 10-K 5 pages This Management and Operations Agreement (This “Agreement”) Is Made as of March 3rd 2025, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Sheffa Enterprises, Inc., a New Jersey Corporation/ Shlomo Pilo, an Individual Residing at Israel (The “Manager”). Recitals 1. Appointment of Manager; Relationship of Company and the Manager

12/34/56

EX-10.4

from 10-K 1 page Extension of Appointment as a Member of the Board of Directors

12/34/56

EX-10.1

from 8-K/A 5 pages This Service Agreement (This “Agreement”) Is Made as of 5th of July, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”),, and Dr. Igal Louria Hayon (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal

12/34/56

EX-10.1

from 10-Q 7 pages Appendix to the Agreement Date July 07, 2019 Signed at October 23, 2022

12/34/56

EX-10.5

from 8-K 3 pages This Service Agreement (This “Agreement”) Is Made as of July 5th, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Eliya Yehuda I.D 025721069, (The “Director”/So Called “Yehuda”). Recitals 1. Appointment of Director; Relationship of Company and Yehuda

12/34/56

EX-10.4

from 8-K 5 pages This Service Agreement (This “Agreement”) Is Made as of 5th of July, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”),, and Dr. Igal Louria Hayon (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal

12/34/56

EX-10.3

from 8-K 5 pages This Operations Agreement (This “Agreement”) Is Made as of July 5th ,2022, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Guy Ofir & Co. Srl a Romanian Company No. J40/1123/2007 or Adv’ Guy Ofir I.D. 172910400069 (The “CFO, Legal Adviser & Director”). Recitals 1. Appointment of CFO, Legal Adviser & Director and It’s Relationship With the Company

12/34/56

EX-10.2

from 8-K 5 pages This Management and Operations Agreement (This “Agreement”) Is Made as of July 5th 2022, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Sheffa Enterprises, Inc., a New Jersey Corporation/ Shlomo Pilo (The “Manager”). Recitals 1. Appointment of Manager; Relationship of Company and the Manager

12/34/56

EX-10.1

from 8-K 3 pages This Service Agreement (This “Agreement”) Is Made as of 30th of June, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Joseph Press (The “Adviser”/So Called “Joseph”). Recitals 1. Appointment of Joseph to Be Medical Adviser; Relationship of Company and Joseph

12/34/56

EX-10.6

from 10-12G/A 27 pages Sponsored Research Agreement With Rambam Med-Tech Ltd

12/34/56